Recent News
November 27,
2019
Zosano Announces Pricing of Registered Direct Offering
November 27,
2019
Zosano Announces Pricing of Registered Direct Offering
* Qtrypta (zolmitriptan intracutaneous microneedle system) is the proposed tradename that has been conditionally approved by FDA. Zosano will seek approval of the tradename when an NDA is filed for the product.